{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T13:48:54Z","timestamp":1782827334491,"version":"3.54.5"},"reference-count":39,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"unspecified","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,6,11]]},"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Endometrial hyperplasia (EH) is a condition that arises due to prolonged exposure of the endometrium to unopposed oestrogen, resulting in abnormal proliferation of endometrial tissue. Atypical hyperplasia, a subtype of EH, is considered a precursor lesion for endometrial cancer (EC). Polycystic ovary syndrome (PCOS) is a recognised risk factor for the development of EH and EC due to chronic anovulation and prolonged oestrogen exposure without progesterone opposition. Despite this increased risk, current clinical guidelines do not recommend routine screening for EH or EC among asymptomatic women with PCOS. The study aims to determine the effectiveness of screening for EH and EC in women with PCOS, particularly among premenopausal women, compared with no screening, reporting the occurrence and clinical outcomes of endometrial pathology among women with PCOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This systematic review will adhere to the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. A comprehensive literature search will be conducted across multiple electronic databases from inception until February 2026. Two reviewers will independently perform study screening, data extraction and methodological quality assessment of the included studies. Discrepancies between reviewers will be resolved through discussion or consultation with a third reviewer. Extracted data will be summarised narratively, and where appropriate, quantitative synthesis will be performed using Joanna Briggs Institute System for the Unified Management, Assessment and Review of Information (JBI SUMARI). Heterogeneity among studies will be assessed, and subgroup and sensitivity analyses will be conducted when feasible.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethical approval is not required for this systematic review and meta-analysis, as it will use data from previously published studies. The results of the review will be published in academic journals and presented at international conferences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD420251274598.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2026-119713","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T13:27:52Z","timestamp":1782826072000},"page":"e119713","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Screening for endometrial hyperplasia and endometrial cancer in premenopausal women with\n                    <b>polycystic ovary syndrome<\/b>\n                    : a systematic review protocol"],"prefix":"10.1136","volume":"16","author":[{"given":"Rajalakshmi","family":"Rajendran","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marva","family":"Abdul Khader","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Shivanna","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prathiksha M","family":"Shet","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niyam","family":"Hegde","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deeya","family":"Karkera","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1257-969X","authenticated-orcid":false,"given":"Girish","family":"Thunga","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"2026063005553248000_16.6.e119713.1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3390\/cancers18010148","article-title":"Endometrial Hyperplasia: Current Insights into Epidemiology, Risk Factors, and Clinical Management","volume":"18","author":"Galani","year":"2025","journal-title":"Cancers (Basel)"},{"key":"2026063005553248000_16.6.e119713.2","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics14222471","article-title":"Endometrial Atypical Hyperplasia and Risk of Endometrial Cancer","volume":"14","author":"Chou","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"2026063005553248000_16.6.e119713.3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/s-0034-1396256","article-title":"New WHO Classification of Endometrial Hyperplasias","volume":"75","author":"Emons","year":"2015","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"2026063005553248000_16.6.e119713.4","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2012-0709-RA"},{"key":"2026063005553248000_16.6.e119713.5","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21058"},{"key":"2026063005553248000_16.6.e119713.6","unstructured":"Zaino RC . Tumours of the uterine corpus: epithelial tumours and precursors. In: WHO classification of tumours of female reproductive organs. 2014: 125\u20136."},{"key":"2026063005553248000_16.6.e119713.7","article-title":"A Histopathological Study of Endometrial Biopsy Samples in Abnormal Uterine Bleeding","volume":"14","author":"Vijayaraghavan","year":"2022","journal-title":"Cureus"},{"key":"2026063005553248000_16.6.e119713.8","first-page":"378","article-title":"A Hospital Based Research to Assess the Clinico-pathological Correlation in Abnormal Uterine Bleeding (AUB)","volume":"14","author":"Ila Priyanka","year":"2022","journal-title":"International Journal of Pharmaceutical and Clinical Research"},{"key":"2026063005553248000_16.6.e119713.9","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"2026063005553248000_16.6.e119713.10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4103\/2278-330X.187575","article-title":"Gynecological cancers: A summary of published Indian data","volume":"5","author":"Maheshwari","year":"2016","journal-title":"South Asian J Cancer"},{"key":"2026063005553248000_16.6.e119713.11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5114\/pm.2017.70589","article-title":"New classification system of endometrial hyperplasia WHO 2014 and its clinical implications","volume":"3","author":"Sobczuk","year":"2017","journal-title":"pm"},{"key":"2026063005553248000_16.6.e119713.12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232231","article-title":"Concurrent and future risk of endometrial cancer in women with endometrial hyperplasia: A systematic review and meta-analysis","volume":"15","author":"Doherty","year":"2020","journal-title":"PLoS ONE"},{"key":"2026063005553248000_16.6.e119713.13","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.2147\/IJWH.S481509","article-title":"A Review of the Risk Factors Associated with Endometrial Hyperplasia During Perimenopause","volume":"16","author":"Wang","year":"2024","journal-title":"Int J Womens Health"},{"key":"2026063005553248000_16.6.e119713.14","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12040886","article-title":"Endometrial Cancer in Reproductive-Aged Females: Etiology and Pathogenesis","volume":"12","author":"Bassette","year":"2024","journal-title":"Biomedicines"},{"key":"2026063005553248000_16.6.e119713.15","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2016.00124","article-title":"Poly Cystic Ovarian Syndrome: An Updated Overview","volume":"7","author":"El Hayek","year":"2016","journal-title":"Front Physiol"},{"key":"2026063005553248000_16.6.e119713.16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20153822","article-title":"Progesterone and Estrogen Signalling in the Endometrium: What Goes Wrong in Endometriosis?","volume":"20","author":"Marquardt","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2026063005553248000_16.6.e119713.17","doi-asserted-by":"crossref","DOI":"10.3892\/ol.2023.13754","article-title":"Risk of endometrial cancer in patients with polycystic ovarian syndrome: A meta\u2011analysis","volume":"25","author":"Johnson","year":"2023","journal-title":"Oncol Lett"},{"key":"2026063005553248000_16.6.e119713.18","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmu012"},{"key":"2026063005553248000_16.6.e119713.19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/00369330221107099","article-title":"Polycystic ovary syndrome and the risk of endometrial, ovarian and breast cancer: An updated meta-analysis","volume":"67","author":"Li","year":"2022","journal-title":"Scott Med J"},{"key":"2026063005553248000_16.6.e119713.20","doi-asserted-by":"publisher","DOI":"10.1111\/cen.15097"},{"key":"2026063005553248000_16.6.e119713.21","doi-asserted-by":"crossref","DOI":"10.1186\/s12014-025-09528-6","article-title":"Present progress in biomarker discovery of endometrial cancer by multi-omics approaches","volume":"22","author":"An","year":"2025","journal-title":"Clin Proteomics"},{"key":"2026063005553248000_16.6.e119713.22","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13133739","article-title":"Current Status of Ovarian and Endometrial Biomarkers in Predicting ART Outcomes","volume":"13","author":"Volovsky","year":"2024","journal-title":"J Clin Med"},{"key":"2026063005553248000_16.6.e119713.23","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.71224","article-title":"A Review on Biomarker-Enhanced Machine Learning for Early Diagnosis and Outcome Prediction in Ovarian Cancer Management","volume":"14","author":"Hormaty","year":"2025","journal-title":"Cancer Med"},{"key":"2026063005553248000_16.6.e119713.24","first-page":"50","article-title":"Polycystic Ovarian Syndrome and the Risk of Ovarian, Endometrial, and Breast Cancer: A Systematic Review and Meta-Analysis","volume":"39","author":"Ghaempanah","year":"2025","journal-title":"Med J Islam Repub Iran"},{"key":"2026063005553248000_16.6.e119713.25","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.3390\/clinpract14050131","article-title":"Assessment of the Validity and Quality of Polycystic Ovarian Syndrome (PCOS) Screening Tools Available for Women Globally: A Systematic Review","volume":"14","author":"Sacca","year":"2024","journal-title":"Clin Pract"},{"key":"2026063005553248000_16.6.e119713.26","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dead156"},{"key":"2026063005553248000_16.6.e119713.27","doi-asserted-by":"crossref","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"2026063005553248000_16.6.e119713.28","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2026063005553248000_16.6.e119713.29","article-title":"Searching for studies: A guide to information retrieval for Campbell systematic reviews","volume":"20","author":"MacDonald","year":"2024","journal-title":"Campbell Syst Rev"},{"key":"2026063005553248000_16.6.e119713.30","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2026063005553248000_16.6.e119713.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2016.01.021"},{"key":"2026063005553248000_16.6.e119713.32","doi-asserted-by":"crossref","unstructured":"Lefebvre C , Glanville J , Briscoe S , et al . Searching for and selecting studies. In: Cochrane handbook for systematic reviews of interventions. Wiley, 2019: 67\u2013107.","DOI":"10.1002\/9781119536604.ch4"},{"key":"2026063005553248000_16.6.e119713.33","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-023-11325-z","article-title":"Kappa statistic considerations in evaluating inter-rater reliability between two raters: which, when and context matters","volume":"23","author":"Li","year":"2023","journal-title":"BMC Cancer"},{"key":"2026063005553248000_16.6.e119713.34","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2026063005553248000_16.6.e119713.35","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"2026063005553248000_16.6.e119713.36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/publications14010004","article-title":"The Newcastle\u2013Ottawa Scale for Assessing the Quality of Studies in Systematic Reviews","volume":"14","author":"Gualdi-Russo","year":"2026","journal-title":"Publications"},{"key":"2026063005553248000_16.6.e119713.37","doi-asserted-by":"crossref","unstructured":"Piper C . System for the Unified Management, Assessment, and Review of Information (SUMARI). jmla 2019;107. doi:10.5195\/jmla.2019.790","DOI":"10.5195\/jmla.2019.790"},{"key":"2026063005553248000_16.6.e119713.38","doi-asserted-by":"publisher","DOI":"10.1111\/biom.12817"},{"key":"2026063005553248000_16.6.e119713.39","doi-asserted-by":"crossref","first-page":"101484","DOI":"10.1016\/j.cegh.2023.101484","article-title":"Introduction to the GRADE tool for rating certainty in evidence and recommendations","volume":"25","author":"Prasad","year":"2024","journal-title":"Clin Epidemiol Glob Health"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2026-119713","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T13:28:06Z","timestamp":1782826086000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2026-119713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,30]]},"published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1136\/bmjopen-2026-119713"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2026-119713","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]}}}